 | BioMarin Pharmaceutical Inc. | |||
| NMS : BMRN || Location: United States | ||||
$90.07-0.4 (-0.44%) |
0.94 M | 89.78 - 91.21 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.064 M |
| March 15, 2024 | 2.964 M |
| Feb. 29, 2024 | 3.056 M |
| Feb. 15, 2024 | 3.262 M |
| Jan. 31, 2024 | 3.175 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.24 | 0.18 | -24.46% |
| 09/30/2023 | 0.24 | 0.21 | -12.06% |
| 06/30/2023 | 0.24 | 0.29 | 22.11% |
| 03/31/2023 | 0.18 | 0.27 | 47.54% |
| 12/31/2022 | -0.07 | 0.00 | 100.00% |
BMRN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 189.775M | Shares Float | 187.289M |
| Short Float | 3.064M | Market Cap | 17093.03M |
| Institution ownership | 0.00% | Insider ownership | 0.843% |
| Earnings Date | 04/24/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.87 | Forward EPS | 2.78 |